Compare IVVD & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | LFMD |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.9M | 218.1M |
| IPO Year | 2021 | 2012 |
| Metric | IVVD | LFMD |
|---|---|---|
| Price | $1.00 | $3.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $8.75 | ★ $9.14 |
| AVG Volume (30 Days) | ★ 3.5M | 1.1M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 79.02 | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,426,000.00 | $12,468,578.00 |
| Revenue This Year | $61.57 | $17.52 |
| Revenue Next Year | $41.42 | $18.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 110.47 | 49.79 |
| 52 Week Low | $0.52 | $2.60 |
| 52 Week High | $3.07 | $7.32 |
| Indicator | IVVD | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.89 | 38.77 |
| Support Level | $0.69 | $3.00 |
| Resistance Level | $1.01 | $3.41 |
| Average True Range (ATR) | 0.08 | 0.25 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 89.30 | 28.92 |
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.